<DOC>
	<DOCNO>NCT02901366</DOCNO>
	<brief_summary>To assess plasma pharmacokinetics , route extent elimination , metabolites FYU-981 single 1 mg oral dose 14C-FYU-981 healthy male subject .</brief_summary>
	<brief_title>Mass Balance Study FYU-981</brief_title>
	<detailed_description />
	<criteria>Japanese healthy adult subject Body mass index : &gt; =18.5 &lt; 25.0 Subjects disease history disease might unsuitable participation clinical study Have participate [ 14C ] study within last 12 month prior dose investigational drug Exposure radiation therapeutic diagnostic reason ( except dental Xrays plain Xrays thorax bony skeleton ) within last 12 month prior dose investigational drug Occupationally expose worker</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Mass balance</keyword>
</DOC>